Inavolisib
CAS 2060571-02-8Small Molecule
Overview
Inavolisib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4650215).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Inavolisib expires 14 Jun 2038 and exclusivity 10 Oct 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
- Canonical SMILES
- C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F
- InChIKey
- SGEUNORSOZVTOL-CABZTGNLSA-N
Verified Supplier Partner
Do you supply Inavolisib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.